Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Change in Acquisitions & Divestments (2018 - 2019)

Lifecore Biomedical, Inc. \De\ has reported Change in Acquisitions & Divestments over the past 9 years, most recently at $68000.0 for Q4 2019.

  • Quarterly results put Change in Acquisitions & Divestments at $68000.0 for Q4 2019, down 65.13% from a year ago — trailing twelve months through Aug 2020 was $68000.0 (down 91.91% YoY), and the annual figure for FY2020 was $364000.0, down 33.21%.
  • Change in Acquisitions & Divestments for Q4 2019 was $68000.0 at Lifecore Biomedical, Inc. \De\, down from $296000.0 in the prior quarter.
  • Over the last five years, Change in Acquisitions & Divestments for LFCR hit a ceiling of $4.4 million in Q1 2015 and a floor of $68000.0 in Q4 2019.
  • Median Change in Acquisitions & Divestments over the past 4 years was $221000.0 (2016), compared with a mean of $813625.0.
  • Biggest five-year swings in Change in Acquisitions & Divestments: crashed 94.66% in 2016 and later plummeted 65.13% in 2019.
  • Lifecore Biomedical, Inc. \De\'s Change in Acquisitions & Divestments stood at $1.0 million in 2015, then plummeted by 76.77% to $233000.0 in 2016, then fell by 16.31% to $195000.0 in 2018, then plummeted by 65.13% to $68000.0 in 2019.
  • The last three reported values for Change in Acquisitions & Divestments were $68000.0 (Q4 2019), $296000.0 (Q3 2019), and $141000.0 (Q2 2019) per Business Quant data.